Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well?

@article{Zeuzem2004HeterogeneousVR,
  title={Heterogeneous virologic response rates to interferon-based therapy in patients with chronic hepatitis C: who responds less well?},
  author={Stefan Zeuzem},
  journal={Annals of internal medicine},
  year={2004},
  volume={140 5},
  pages={370-81}
}
The introduction of new agents and regimens for the treatment of chronic hepatitis C, such as pegylated interferons and combination therapy with ribavirin, has resulted in substantial improvements in sustained virologic response rates. However, treatment remains a challenge, particularly for certain patient populations, because several virus-related and patient-related factors are associated with a lower virologic response to therapy. Hepatitis C virus genotype 1 and a high baseline viral load… CONTINUE READING

Connections & Topics

Mentioned Connections BETA
Hepatitis C virus genotype 1 and a high baseline viral load are the major viral factors associated with lower response .
Hepatitis C virus genotype 1 and a high baseline viral load are the major viral factors associated with lower response .
The introduction of new agents and regimens for the treatment of chronic hepatitis C , such as pegylated interferons and combination therapy with ribavirin , has resulted in substantial improvements in sustained virologic response rates .
The introduction of new agents and regimens for the treatment of chronic hepatitis C , such as pegylated interferons and combination therapy with ribavirin , has resulted in substantial improvements in sustained virologic response rates .
Hepatitis C virus genotype 1 and a high baseline viral load are the major viral factors associated with lower response .
Hepatitis C virus genotype 1 and a high baseline viral load are the major viral factors associated with lower response .
Hepatitis C virus genotype 1 and a high baseline viral load are the major viral factors associated with lower response .
Hepatitis C virus genotype 1 and a high baseline viral load are the major viral factors associated with lower response .
Hepatitis C virus genotype 1 and a high baseline viral load are the major viral factors associated with lower response .
The introduction of new agents and regimens for the treatment of chronic hepatitis C , such as pegylated interferons and combination therapy with ribavirin , has resulted in substantial improvements in sustained virologic response rates .
The introduction of new agents and regimens for the treatment of chronic hepatitis C , such as pegylated interferons and combination therapy with ribavirin , has resulted in substantial improvements in sustained virologic response rates .
The introduction of new agents and regimens for the treatment of chronic hepatitis C , such as pegylated interferons and combination therapy with ribavirin , has resulted in substantial improvements in sustained virologic response rates .
The introduction of new agents and regimens for the treatment of chronic hepatitis C , such as pegylated interferons and combination therapy with ribavirin , has resulted in substantial improvements in sustained virologic response rates .
All Topics